Plus Therapeutics Inc.

0.66
-0.06 (-8.97%)
At close: Mar 03, 2025, 3:59 PM
0.66
-0.33%
After-hours: Mar 03, 2025, 07:08 PM EST

Plus Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98
Cash & Equivalents 8.55M 18.12M 18.4M 8.35M 17.55M 5.26M 9.55M 12.56M 14.34M 14.62M 15.51M 25.72M 36.92M 52.67M 12.85M 12.61M 11.46M 8.9M 8.01M 2.84M 2.82M 5.11M 2.7M 7.48M 2.47M 35K
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.98M 7.84M 10.58M 11.45M 19.88M 31.25M 37.01M n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a 350K n/a n/a 85K 250K 459K 280K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 32K 12K 16K 16K 72K 11.67M 2.57M 2.34M 1.87M 2.11M 3.16M 3.09M 2.12M 916K 500K 1.05M 837K 961K 458K 236K 332K 562K 1.02M 241K n/a n/a
Receivables n/a n/a 7K 59K 1.17M 233K 145K 1.24M 1.31M 1.36M 4.26M 4.04M 2.49M 2.2M 2.02M 1.87M 75K 288K 854K 917K 1.29M 1.24M 463K 693K n/a n/a
Inventory n/a n/a -7K -59K 107K 107K 3.18M 3.73M 4.3M 4.83M 3.69M 3.17M 3.32M 3.38M 2.59M 2.14M n/a 164K 258K 379K 831K 1.15M 1.69M 2.28M n/a n/a
Other Current Assets 1.28M 3.7M 1.32M 770K 997K 4.05M 1.99M 1.22M 2.55M 1.67M 1.23M 1.05M 606K 707K 638K 598K 698K 648K 583K 930K 526K 843K 851K 882K n/a n/a
Total Current Assets 9.83M 21.82M 19.72M 9.18M 19.82M 9.65M 14.86M 18.75M 21.24M 21.69M 24.58M 33.98M 43.34M 58.95M 18.1M 17.23M 12.24M 13.98M 17.54M 15.64M 16.92M 28.21M 36.95M 48.34M 2.47M 35K
Property-Plant & Equipment 1.11M 1.57M 1.82M 2.46M 2.96M 2.3M 3.05M 1.16M 1.63M 1.58M 1.05M 2.17M 1.71M 1.68M 1.31M 2.55M 3.43M 4.24M 4.26M 3.08M 3.82M 3.63M 5.17M 3.69M n/a n/a
Goodwill & Intangibles 414K 466K 423K 458K 372K 372K 11.13M 12.37M 12.95M 13.34M 13.27M 3.92M 4.11M 4.33M 4.56M 4.78M 5M 5.69M 5.91M 6.51M 7.02M 6.92M n/a n/a n/a n/a
Total Long-Term Assets 1.55M 2.05M 2.26M 2.93M 3.4M 14.34M 16.75M 15.86M 16.45M 17.03M 17.48M 9.27M 8.2M 7.39M 6.65M 8.38M 9.27M 10.89M 10.63M 9.82M 11.17M 11.11M 6.19M 3.93M n/a n/a
Total Assets 11.39M 23.87M 21.98M 12.11M 23.23M 23.99M 31.61M 34.61M 37.7M 38.72M 42.06M 43.25M 51.53M 66.35M 24.75M 25.61M 21.51M 24.87M 28.17M 25.47M 28.09M 39.32M 43.14M 52.27M 5.58M 1.02M
Account Payables 4.76M 8.36M 2.61M 789K 327K 721K 1.3M 1.33M 1.01M 949K 965K 1.58M 272K -5.51B 1.15M 464K 479K 729K 933K 481K n/a -19.41M -900.68M n/a n/a n/a
Deferred Revenue n/a n/a 1.42M 1.26M 2.95M 1.85M 3.27M 215K 221K 191K 138K 35K 3.52B 5.51B 7.63B 16.47B 18.75B 23.91B 17.31B 1.5B n/a 19M 900M n/a n/a n/a
Short-Term Debt 4.1M 1.83M 1.83M 6.47M 11.33M 14.2M 13.62M 6.63M n/a 7.36M 3.19M 19.57M 2.49M 6.45M 2.71M 2.05M 721K 999K 952K 938K 1.43M 410K 676K 115K n/a n/a
Other Current Liabilities 1.87M 1.66M 1.43M 1.28M 2.83M 2.64M 3.49M 4.33M 7.21M 7.41M 10.61M -3.57M 5.06M 5.52B 4.33M 4.62M 6.87M 4.86M 5.2M 1.85M 3.05M 21.91M 901.83M 1.36M n/a n/a
Total Current Liabilities 10.73M 11.85M 5.87M 8.54M 14.49M 17.56M 18.41M 12.5M 8.44M 15.92M 14.91M 17.61M 7.82M 13.22M 8.18M 7.13M 8.07M 6.59M 7.08M 3.27M 4.48M 2.91M 1.83M 1.48M n/a n/a
Long-Term Debt 85K 3.93M 5.27M 528K 646K n/a n/a 11.01M 16.68M 18.04M 23.1M 12.9M 21.96M 13.26M 5.58M 5.04M 237K 1.16M 1.56M 1.13M 1.16M 770M 1.93M 255K n/a 209K
Other Long-Term Liabilities 1.92M 1.64M 1K 7K 6.94M 1.04M 107K 17K 374K 10.46M 922K 2.25M 2.54M 6.16M 4.62M 2.06M 1M 900K 5.33M n/a n/a -769.23M 900K 1.2M n/a -209K
Total Long-Term Liabilities 2.01M 5.57M 5.28M 535K 7.58M 1.21M 201K 11.12M 17.05M 28.5M 24.02M 19.18M 33.77M 30.25M 20.22M 26.19M 22.84M 29.09M 27.31M 9.37M 8.7M 10.41M 2.83M 1.46M n/a 209K
Total Liabilities 12.74M 17.42M 11.14M 9.07M 22.07M 18.77M 18.61M 23.62M 25.49M 44.42M 38.93M 36.8M 41.59M 43.47M 28.41M 33.33M 30.91M 35.68M 34.4M 12.64M 13.18M 13.32M 4.66M 2.93M n/a 209K
Total Debt 4.18M 5.64M 6.99M 7M 11.85M 14.2M 13.62M 17.64M 16.68M 25.4M 26.29M 22.69M 24.45M 19.71M 5.5M 7.09M 958K 2.16M 2.51M 2.07M 1.87M 1.18M 2.6M 370K n/a 209K
Common Stock 5K 34K 16K 7K 4K 15K 58K 22K 195K 99K 71K 66K 57K 52K 40K 31K 26K 22K 18K 17K 17K 17K 15K 15K n/a n/a
Retained Earnings -480.5M -467.19M -446.91M -433.51M -425.27M -414.38M -401.75M -379.06M -357.02M -338.27M -300.9M -274.73M -242.45M -210M -182.5M -162.17M -132.13M -103.46M -78.01M -51.48M -49.38M -40.1M -27.1M -15.89M n/a n/a
Comprehensive Income -0.00 n/a n/a n/a n/a 1.22M 1.39M 1.26M 996K 700K 256K -8.61M -7.99M -7.61M -6.94M -6.23M -4K -14K -16K -32K 26K 159K 350K 180K n/a n/a
Shareholders Equity -1.35M 6.45M 10.84M 3.03M 1.16M 5.22M 13M 10.99M 12.21M -5.7M 3.13M 6.46M 9.95M 22.87M -3.66M -7.72M -9.4M -10.81M -6.23M 12.83M 14.91M 26M 38.49M 49.34M -6.15M 108K
Total Investments n/a n/a n/a n/a n/a n/a n/a n/a 350K n/a n/a 85K 250K 459K 280K n/a n/a 3.98M 7.84M 10.58M 11.45M 19.88M 31.25M 37.01M n/a n/a